Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2016 3
2017 3
2018 5
2019 19
2020 27
2021 22
2022 14
2023 18
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.
Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, Moy B, Wildes TM, Klepin HD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Muss HB, Cohen HJ, Gross CP, Ji J. Sedrak MS, et al. J Cancer Surviv. 2024 Apr 28. doi: 10.1007/s11764-024-01594-3. Online ahead of print. J Cancer Surviv. 2024. PMID: 38678525
Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.
Soto-Perez-de-Celis E, Dale W, Katheria V, Kim H, Fakih M, Chung VM, Lim D, Mortimer J, Cabrera Chien L, Charles K, Roberts E, Vazquez J, Moreno J, Lee T, Fernandes Dos Santos Hughes S, Sedrak MS, Sun CL, Li D. Soto-Perez-de-Celis E, et al. Among authors: sedrak ms. Cancer. 2024 Apr 17. doi: 10.1002/cncr.35333. Online ahead of print. Cancer. 2024. PMID: 38630903
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.
Lustberg M, Fan-Havard P, Wong FL, Hill K, Phelps MA, Herrera KW, Tsai NC, Synold T, Feng Y, Kalu C, Sedrak MS, Yee LD. Lustberg M, et al. Among authors: sedrak ms. Breast Cancer Res Treat. 2024 Jan 27. doi: 10.1007/s10549-023-07223-4. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38280052
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
Ji J, Bae M, Sun CL, Wildes TM, Freedman RA, Magnuson A, O'Connor T, Moy B, Klepin HD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Gross CP, Cohen HJ, Muss HB, Sedrak MS. Ji J, et al. Among authors: sedrak ms. Cancer. 2024 Mar 15;130(6):936-946. doi: 10.1002/cncr.35105. Epub 2023 Nov 14. Cancer. 2024. PMID: 37962093
Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study.
Nelson RA, Soto-Perez-de-Celis E, Chlebowski RT, Schonberg M, Mortimer J, Pan K, Hou L, Neuhouser ML, Reding KW, Saquib N, Wactawski-Wende J, Wolfson E, Sedrak MS, Kruper L. Nelson RA, et al. Among authors: sedrak ms. J Natl Compr Canc Netw. 2023 Jun;21(6):636-644.e13. doi: 10.6004/jnccn.2023.7015. J Natl Compr Canc Netw. 2023. PMID: 37308127
92 results